Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration

In conclusion, the findings of the current study demonstrated that silencing Nanog combined with Cisplatin could be a potent treatment approach for lung cancer patients.PMID:35398618 | DOI:10.1016/j.prp.2022.153869

Source: Pathology, Research and Practice - April 10, 2022 Category: Pathology Authors: Basira Najafzadeh Rouhollah Motafakkerazad Souzan Najafi Mohammad Amini Hajar Alemohammad Parisa Vasefifar Behzad Baradaran Source Type: research